CIK 0000872912 · Non-accelerated filer<br>Smaller reporting company
DELCATH SYSTEMS, INC.
Sign in to watch- Ticker
- DCTH
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061245881
- Phone
- (518) 743-8892
- Business address
- 566 QUEENSBURY AVENUE, QUEENSBURY, NY, 12804
- Former names
- DELCATH SYSTEMS, INC., DELCATH SYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $488,508
- in 1 filing
Net −$488,508. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-08 | MICHEL GERARD J Chief Executive Officer | Purchase | +34,000 | $2.94 | $100K | 262,345 |
| 2023-11-17 | Rosalind Advisors, Inc. Director | Purchase | +100,000 | $2.40 | $240K | 1,038,828 |
| 2023-11-17 | Pennell Sandra SVP of Finance, PFO and PAO | Purchase | +30,000 | $2.43 | $73K | 30,000 |
| 2023-11-16 | Vukovic Vojo Chief Medical Officer | Purchase | +60,000 | $2.48 | $149K | 60,000 |
| 2023-11-16 | Hoffman David L. See Remarks | Purchase | +40,000 | $2.48 | $99K | 40,000 |
| 2023-10-13 | Purpura John Chief Operating Officer | Purchase | +14,505 | $3.44 | $50K | 41,526 |
| 2023-08-21 | Sylvester John Richard Director | Purchase | +10,550 | $4.80 | $51K | 10,550 |
| 2023-08-21 | Rosalind Advisors, Inc. Director | Option exercise · Tranche A Warrant | +0 | $1,000.00 | $0 | 0 |
| 2023-08-18 | MICHEL GERARD J Chief Executive Officer | Option exercise | +31,110 | $4.50 | $140K | 228,345 |
| 2023-08-18 | MICHEL GERARD J Chief Executive Officer | Option exercise · Tranche A Warrants to Purchase Common Stock | −31,110 | $0.13 | $4K | 0 |
| 2023-06-12 | SALAMON STEVEN A J Director | Grant or award · Stock Option (Right to Buy) | +19,682 | 19,682 | ||
| 2023-06-12 | Aharon Gil Director | Grant or award · Stock Option (Right to Buy) | +19,682 | 19,682 | ||
| 2023-06-12 | Sylvester John Richard Director | Grant or award · Stock Option (Right to Buy) | +19,682 | 19,682 | ||
| 2023-06-12 | Purpura John Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +59,813 | 59,813 | ||
| 2023-06-12 | Muir Kevin See Remarks | Grant or award · Stock Option (Right to Buy) | +59,813 | 59,813 | ||
| 2023-06-12 | Pennell Sandra See Remarks | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2023-06-12 | STOLL ROGER G PHD Director | Grant or award · Stock Option (Right to Buy) | +19,682 | 19,682 | ||
| 2023-06-12 | Hoffman David L. See Remarks | Grant or award · Stock Option (Right to Buy) | +59,813 | 59,813 | ||
| 2023-06-12 | MICHEL GERARD J Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +168,887 | 168,887 | ||
| 2023-06-12 | CZEREPAK ELIZABETH Director | Grant or award · Stock Option (Right to Buy) | +19,682 | 19,682 |
Page 6 of 7 · 138 trades